Predictive Oncology (NASDAQ:POAI) Stock Jumps After Earnings: Now What?
Anyone looking into the action in the premarket period today might have noticed the strong gains made by the Predictive Oncology (NASDAQ:POAI) stock. The company, which deploys artificial intelligence for the purposes of medicine discovery and personalised medicine, saw its stock up by as much as 5% after it announced its financial results for the fiscal second quarter yesterday.
In this situation it might be a good idea for investors to perhaps take a closer look at the company’s financial results in the quarter that ended on June 30, 2021.
Predictive Oncology managed to bring in net proceeds to the tune of as much as $19.4 million as a result of a registered direct offering during the second quarter. That offering brought the cash balance of the company to as much as $44.9 million at the end of the quarter. In the prior year period, the company had a cash balance of only $3.4 million.
On the other hand the total equity belong to stockholders also went up and hit as much as $53.1 million to clock a remarkable rise of as much as $50.4 million from the prior year period. It is likely that the Predictive Oncology stock is going to be on the radars of investors this morning.
